We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IBM Watson Turns Oncogenes Into Drug Targets

News   Aug 09, 2017 | Original story from Medical College of Georgia at Augusta University

 
IBM Watson Turns Oncogenes Into Drug Targets

Dr. Ravindra Kolhe, breast and molecular pathologist at the Medical College of Georgia at Augusta University

 
 
 

RELATED ARTICLES

Bioinformatics Tool Enables Analysis of Complex Plant Genomes

News

Bioinformatics researchers from Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Martin Luther University Halle-Wittenberg (MLU) and Leibniz Institute of Plant Biochemistry (IPB) have now published "Kmasker plants", a program that allows the identification of repetitive sequences and thus facilitates the analysis of plant genomes.

READ MORE

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Long-hidden Metabolic System Unlocks Cancer Secrets

News

Researchers have identified a long-hidden metabolic system in cells, which could provide a new opportunity to find ways to suppress cell proliferation in cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE